| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/02/2012 | CN101928700B Protein kinase PFTK1 monoclonal antibody and preparation method thereof |
| 05/02/2012 | CN101892177B Antifungal lipopeptid-containing skin liniment and preparation method thereof |
| 05/02/2012 | CN101864422B Composition type expression promoter of malvastrum yellow vein viruses satellite |
| 05/02/2012 | CN101613676B Rat bone marrow tumour cell NSO and preparation method and application thereof |
| 05/01/2012 | US8168772 Nucleic acids encoding novel chimeric C15/prM/E dengue virus immunogens prepared by DNA shuffling |
| 05/01/2012 | US8168758 Anti-MN antibodies and methods of using same |
| 05/01/2012 | US8168755 Antibodies specific to heterodimers of Bcl-2 family and uses thereof |
| 05/01/2012 | US8168751 Interferon alpha mutant and its polyethylene glycol derivative |
| 05/01/2012 | US8168749 Stimulating neurite outgrowth using Tctex-1-related polypeptides |
| 05/01/2012 | US8168426 Multiple inducible gene regulation system |
| 05/01/2012 | US8168418 Expression of HIV polypeptides and production of virus-like particles |
| 05/01/2012 | US8168416 Modified lecithin-cholesterol acyltransferase enzymes |
| 05/01/2012 | US8168411 Highly thermostable fluorescent proteins |
| 05/01/2012 | US8168408 Cytolethal distending toxins and detection of Campylobacter bacteria using the same as a target |
| 05/01/2012 | US8168407 Method of synthesizing a suppressor TRNA, DNA construct and use thereof for producing a protein including a non-natural amino acid |
| 05/01/2012 | US8168405 Covalent tethering of functional groups to proteins and substrates therefor |
| 05/01/2012 | US8168392 Tetrahydrofolate synthetase gene |
| 05/01/2012 | US8168205 Streptococcus pneumoniae polypeptides |
| 05/01/2012 | US8168198 Therapeutic agent for polycystic ovary syndrome (PCOS) |
| 05/01/2012 | US8168188 Antibody and utilization of the same |
| 05/01/2012 | US8168186 Therapeutic using a bispecific antibody |
| 05/01/2012 | CA2583910C Angiopoietin-2 specific binding agents |
| 05/01/2012 | CA2450548C Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments |
| 05/01/2012 | CA2335318C Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 05/01/2012 | CA2333466C Gbs toxin receptor |
| 05/01/2012 | CA2281620C Neurturin receptor |
| 04/26/2012 | WO2012054554A2 Thermostable trichoderma cellulase |
| 04/26/2012 | WO2012052170A1 Secretion of recombinant polypeptides in the extracellular medium of diatoms |
| 04/26/2012 | WO2012028958A3 Antibody for colorectal cancer marker |
| 04/26/2012 | WO2012028523A3 Prokaryotic expression construct |
| 04/26/2012 | WO2012006490A3 Dual variable domain immunoglobulins and uses thereof |
| 04/26/2012 | WO2010091203A3 Rna-and dna-copying enzymes |
| 04/26/2012 | US20120101260 Sustained drug delivery system |
| 04/26/2012 | US20120101256 Multispecific peptides |
| 04/26/2012 | US20120101006 Methods and Compositions for the Production of Orthogonal tRNA-Aminoacyl tRNA Synthetase Pairs |
| 04/26/2012 | US20120100632 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 04/26/2012 | US20120100576 Perfusion bioreactor |
| 04/26/2012 | US20120100575 Antibodies having altered effector function and methods for making the same |
| 04/26/2012 | US20120100574 Flavivirus-based system for production of hepatitis c virus (hcv) |
| 04/26/2012 | US20120100573 Cytomegalovirus intron a fragments |
| 04/26/2012 | US20120100570 Site-Specific Incorporation of Redox Active Amino Acids into Proteins |
| 04/26/2012 | US20120100565 High pressure enzymatic digestion system for protein characterization |
| 04/26/2012 | US20120100553 Cho/cert cell lines |
| 04/26/2012 | US20120100236 Chromobacterium bioactive compositions and metabolites |
| 04/26/2012 | US20120100169 Vaccine for Cervical Cancer |
| 04/26/2012 | US20120100166 Ang-2 Binding Complexes and Uses Thereof |
| 04/26/2012 | US20120100159 Anti-tat226 antibodies and immunoconjugates |
| 04/26/2012 | US20120100152 Anti-human cd52 immunoglobulins |
| 04/26/2012 | US20120100148 Anti-ferroportin 1 monoclonal antibodies and uses thereof |
| 04/26/2012 | US20120100144 Biomarker and Treatment for Cancer |
| 04/26/2012 | US20120100143 Immunogenic proteins from genome-derived outer membrane of leptospira and compositions and methods based thereon |
| 04/26/2012 | US20120100140 Stabilized fc polypeptides with reduced effector function and methods of use |
| 04/26/2012 | US20120100099 Fusion proteins having mutated immunoglobulin hinge region |
| 04/26/2012 | US20120100074 Humanized antibodies against light and uses thereof |
| 04/26/2012 | CA2815080A1 Anti-folate receptor alpha antibody glycoforms |
| 04/26/2012 | CA2815070A1 Thermostable trichoderma cellulase |
| 04/25/2012 | EP2444499A2 Amino acid substituted molecules |
| 04/25/2012 | EP2444495A1 Secretion of recombinant polypeptides in the extracellular medium of diatoms |
| 04/25/2012 | EP2444484A1 Method for producing antibodies using cancer cells |
| 04/25/2012 | EP2444409A2 Compositions and methods for the treatment of immune related diseases |
| 04/25/2012 | EP2443248A1 IMPROVEMENT OF LONG CHAIN OMEGA-3 AND OMEGA-6 POLYUNSATURATED FATTY ACID BIOSYNTHESIS BY EXPRESSION OF ACYL-CoA LYSOPHOSPHOLIPID ACYLTRANSFERASES |
| 04/25/2012 | EP2443228A1 Zymomonas with improved arabinose utilization |
| 04/25/2012 | EP1689766B1 Expression in filamentous fungi of protease inhibitors and variants thereof |
| 04/25/2012 | EP1610127B1 N1,n12-diacetylspermine as tumor marker |
| 04/25/2012 | EP0958046B8 Cell separation composition, kit and method |
| 04/25/2012 | EP0773997B2 Htk ligand |
| 04/25/2012 | CN102428174A 工程再造mRNA一级结构以增强蛋白质产生 Reengineering mRNA primary structure to enhance protein production |
| 04/25/2012 | CN101629186B 以家蚕作为宿主生产重组蝎毒素蛋白的方法 Silkworm as a production method for recombinant host scorpion toxin protein |
| 04/24/2012 | US8163894 DNA for eukaryotic expression of CymR |
| 04/24/2012 | US8163886 such as recombinant proteins (biodrugs) made via engineered host cells; using polymers solubilizable under a given set of conditions |
| 04/24/2012 | US8163884 Interleukin-21 receptor binding proteins |
| 04/24/2012 | US8163883 Gene encoding labyrinthin, a marker for cancer |
| 04/24/2012 | US8163882 Polypeptide variants with altered effector function |
| 04/24/2012 | US8163881 Immunoglobulin molecules with improved characteristics |
| 04/24/2012 | US8163879 Fusion molecules and IL-15 variants |
| 04/24/2012 | US8163873 Isolated microtubule-associated protein tau peptides and kit |
| 04/24/2012 | US8163871 Enzymatic reactions in the presence of keto acids |
| 04/24/2012 | US8163542 Potent combinations of mRNA transport elements |
| 04/24/2012 | US8163532 Microorganisms with a reactivation system for cob(I)alamin-dependent methionine synthase |
| 04/24/2012 | US8163529 Nicking endonuclease methods and compositions |
| 04/24/2012 | US8163522 Human TNF receptor |
| 04/24/2012 | US8163521 Self-assembled proteins and related methods and protein structures |
| 04/24/2012 | US8163520 Nucleic acids encoding a chimeric polypeptide comprising IL-7 and HGF-beta chain and methods of use |
| 04/24/2012 | US8163519 Fungal immunomodulatory protein (FIP) prepared by microorganisms and uses thereof |
| 04/24/2012 | US8163518 Microwave assisted deglycosylation of proteins for molecular weight determination by mass spectrometry |
| 04/24/2012 | US8163514 Methods of cleaving DNA with rationally-designed meganucleases |
| 04/24/2012 | US8163288 S. aureus polypeptides and antibodies |
| 04/24/2012 | US8163285 Nogo-A binding molecules and pharmaceutical use thereof |
| 04/24/2012 | US8163279 IL3Rα antibody conjugates and uses thereof |
| 04/24/2012 | CA2485959C Polypeptide cleavage process |
| 04/24/2012 | CA2452447C Antagonistic anti-htnfsf13b human antibodies |
| 04/24/2012 | CA2350226C Protein expression vector and utilization thereof |
| 04/24/2012 | CA2339529C Isolated and purified human soluble guanylyl cyclase .alpha.1/.beta.1 (hsgc .alpha.1/.beta.1) |
| 04/24/2012 | CA2277141C Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure |
| 04/19/2012 | WO2012051111A2 Human oncostatin m antibodies and methods of use |
| 04/19/2012 | WO2012050175A1 Method for producing glycoprotein having mannose residue as non-reducing end of sugar chain |
| 04/19/2012 | WO2011137344A3 Anti-s1p antibody treatment of patients with ocular disease |
| 04/19/2012 | US20120096583 Methods and compositions for enhanced gene expression through intron free energy reduction |
| 04/19/2012 | US20120096571 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases |
| 04/19/2012 | US20120096569 Anti-il-6 antibodies,compositions, methods and uses |